Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial (Trials, (2022), 23, 1, (45), 10.1186/s13063-021-05968-1)

Christopher Kai Shun Leung, Seraph Tianmin Ren, Poemen Pui Man Chan, Kelvin Ho Nam Wan, Aziz Ka Wai Kam, Gilda Wing Ki Lai, Vivian Sheung Man Chiu, Match Wai Lun Ko, Cedric Ka Fai Yiu, Marco Chak Yan Yu

Research output: Journal article publicationComment/debate/erratum

1 Citation (Scopus)

Abstract

Following the publication of the original article [1], we were notified that the received date of the paper was 26 November 2020, and not 8 March 2021. The original article has been corrected.

Original languageEnglish
Article number134
JournalTrials
Volume23
Issue number1
DOIs
Publication statusPublished - Dec 2022

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial (Trials, (2022), 23, 1, (45), 10.1186/s13063-021-05968-1)'. Together they form a unique fingerprint.

Cite this